المؤلفون: Gauthier H; Service de neurologie, hôpital Henri-Mondor, centre hospitalier universitaire Henri-Mondor, AP-HP, 51, avenue du Maréchal-de-Lattre-de-Tassigny, 94010 Créteil, France; CRC SEP Grand-Paris-Est, hôpital Henri-Mondor, AP-HP, Créteil, France., Zedet M; Service de neurologie, hôpital Henri-Mondor, centre hospitalier universitaire Henri-Mondor, AP-HP, 51, avenue du Maréchal-de-Lattre-de-Tassigny, 94010 Créteil, France; CRC SEP Grand-Paris-Est, hôpital Henri-Mondor, AP-HP, Créteil, France; EA4391, université Paris-Est, Créteil, France., Wahab A; Service de neurologie, hôpital Henri-Mondor, centre hospitalier universitaire Henri-Mondor, AP-HP, 51, avenue du Maréchal-de-Lattre-de-Tassigny, 94010 Créteil, France; CRC SEP Grand-Paris-Est, hôpital Henri-Mondor, AP-HP, Créteil, France; EA4391, université Paris-Est, Créteil, France., Baldé S; CRC SEP Grand-Paris-Est, hôpital Henri-Mondor, AP-HP, Créteil, France., Bapst B; EA4391, université Paris-Est, Créteil, France; Service de neuroradiologie, hôpital Henri-Mondor, AP-HP, Créteil, France., Lafont C; IMRB, Inserm, université Paris-Est-Créteil, 94010 Créteil, France; Service de santé publique, hôpital Henri-Mondor, AP-HP, 94010 Créteil, France., Créange A; Service de neurologie, hôpital Henri-Mondor, centre hospitalier universitaire Henri-Mondor, AP-HP, 51, avenue du Maréchal-de-Lattre-de-Tassigny, 94010 Créteil, France; CRC SEP Grand-Paris-Est, hôpital Henri-Mondor, AP-HP, Créteil, France; EA4391, université Paris-Est, Créteil, France. Electronic address: alain.creange@aphp.fr.

المصدر: Revue neurologique [Rev Neurol (Paris)] 2024 Sep; Vol. 180 (7), pp. 673-681. Date of Electronic Publication: 2024 May 09.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Masson Country of Publication: France NLM ID: 2984779R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 0035-3787 (Print) Linking ISSN: 00353787 NLM ISO Abbreviation: Rev Neurol (Paris) Subsets: MEDLINE

مواضيع طبية MeSH: Metabolic Syndrome*/epidemiology , Metabolic Syndrome*/complications , Phenotype* , Multiple Sclerosis*/epidemiology , Multiple Sclerosis*/complications , Disease Progression*, Humans ; Male ; Female ; Adult ; Middle Aged ; Cohort Studies ; Multiple Sclerosis, Chronic Progressive/epidemiology ; Multiple Sclerosis, Chronic Progressive/blood ; Multiple Sclerosis, Relapsing-Remitting/epidemiology ; Multiple Sclerosis, Relapsing-Remitting/complications ; Multiple Sclerosis, Relapsing-Remitting/blood ; Comorbidity ; Prevalence

المؤلفون: Bava CI; NICO - Neuroscience Institute Cavalieri Ottolenghi, Orbassano, Italy; CRESM Biobank, University Hospital San Luigi Gonzaga, Orbassano, Italy; Department of Neurology and CRESM, University Hospital San Luigi Gonzaga, Orbassano, Italy. Electronic address: c.bava@sanluigi.piemonte.it., Valentino P; NICO - Neuroscience Institute Cavalieri Ottolenghi, Orbassano, Italy., Malucchi S; Department of Neurology and CRESM, University Hospital San Luigi Gonzaga, Orbassano, Italy., Bottero R; Department of Neurology and CRESM, University Hospital San Luigi Gonzaga, Orbassano, Italy., Martire S; CRESM Biobank, University Hospital San Luigi Gonzaga, Orbassano, Italy; Department of Neuroscience 'Rita Levi Montalcini', University of Turin, Italy., Sapio AD; CRESM Biobank, University Hospital San Luigi Gonzaga, Orbassano, Italy; Department of Neurology and CRESM, University Hospital San Luigi Gonzaga, Orbassano, Italy., Bertolotto A; NICO - Neuroscience Institute Cavalieri Ottolenghi, Orbassano, Italy.

المصدر: Multiple sclerosis and related disorders [Mult Scler Relat Disord] 2024 Aug; Vol. 88, pp. 105748. Date of Electronic Publication: 2024 Jun 29.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier B. V Country of Publication: Netherlands NLM ID: 101580247 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2211-0356 (Electronic) Linking ISSN: 22110348 NLM ISO Abbreviation: Mult Scler Relat Disord Subsets: MEDLINE

مواضيع طبية MeSH: Neurofilament Proteins*/blood , Multiple Sclerosis, Chronic Progressive*/blood , Multiple Sclerosis, Chronic Progressive*/drug therapy , Multiple Sclerosis, Chronic Progressive*/epidemiology, Humans ; Female ; Male ; Adult ; Cross-Sectional Studies ; Middle Aged ; Prevalence ; Biomarkers/blood ; Young Adult ; Multiple Sclerosis, Relapsing-Remitting/blood ; Multiple Sclerosis, Relapsing-Remitting/drug therapy ; Multiple Sclerosis, Relapsing-Remitting/epidemiology ; Multiple Sclerosis/blood ; Multiple Sclerosis/drug therapy ; Multiple Sclerosis/epidemiology ; Aged ; Immunosuppressive Agents/therapeutic use ; Toluidines/therapeutic use ; Crotonates/therapeutic use ; Adolescent

المؤلفون: Herranz E; Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Charlestown, MA 02129, USA.; Harvard Medical School, Boston, MA 02115, USA., Treaba CA; Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Charlestown, MA 02129, USA.; Harvard Medical School, Boston, MA 02115, USA., Barletta VT; Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Charlestown, MA 02129, USA.; Harvard Medical School, Boston, MA 02115, USA., Mehndiratta A; Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Charlestown, MA 02129, USA., Ouellette R; Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Charlestown, MA 02129, USA.; Department of Clinical Neuroscience, Karolinska Institutet, 141 86 Stockholm, Sweden.; Department of Radiology, Karolinska University Hospital, 141 86 Stockholm, Sweden., Sloane JA; Department of Neurology, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA., Ionete C; Department of Neurology, UMass Chan Medical School, Worcester, MA 01605, USA., Babu S; Harvard Medical School, Boston, MA 02115, USA.; Department of Neurology, Massachusetts General Hospital, Boston, MA 02114, USA., Mastantuono M; Neurology Section, Department of Neuroscience, Biomedicine and Movement Sciences, University of Verona, Verona 53593, Italy.; Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel 4058, Switzerland., Magon S; Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel 4058, Switzerland., Loggia ML; Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Charlestown, MA 02129, USA.; Harvard Medical School, Boston, MA 02115, USA.; Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, MA 02114, USA., Makary MM; Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Charlestown, MA 02129, USA.; Harvard Medical School, Boston, MA 02115, USA.; Systems and Biomedical Engineering Department, Faculty of Engineering, Cairo University, Giza 12613, Egypt., Hooker JM; Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Charlestown, MA 02129, USA.; Harvard Medical School, Boston, MA 02115, USA., Catana C; Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Charlestown, MA 02129, USA.; Harvard Medical School, Boston, MA 02115, USA., Kinkel RP; University of California San Diego, Department of Neuroscience, San Diego, CA 92093, USA., Nicholas R; Department of Brain Sciences, Faculty of Medicine, Imperial College London, London SW7 2BX, UK., Klawiter EC; Harvard Medical School, Boston, MA 02115, USA.; Department of Neurology, Massachusetts General Hospital, Boston, MA 02114, USA., Magliozzi R; Neurology Section, Department of Neuroscience, Biomedicine and Movement Sciences, University of Verona, Verona 53593, Italy.; Department of Brain Sciences, Faculty of Medicine, Imperial College London, London SW7 2BX, UK., Mainero C; Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Charlestown, MA 02129, USA.; Harvard Medical School, Boston, MA 02115, USA.

المصدر: Brain : a journal of neurology [Brain] 2024 Jul 05; Vol. 147 (7), pp. 2566-2578.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 0372537 Publication Model: Print Cited Medium: Internet ISSN: 1460-2156 (Electronic) Linking ISSN: 00068950 NLM ISO Abbreviation: Brain Subsets: MEDLINE

مواضيع طبية MeSH: Receptors, GABA*/metabolism , Receptors, GABA*/genetics , Positron-Emission Tomography*/methods , Meninges*/metabolism , Meninges*/diagnostic imaging , Meninges*/pathology , Multiple Sclerosis*/metabolism , Multiple Sclerosis*/diagnostic imaging , Multiple Sclerosis*/pathology, Humans ; Female ; Male ; Middle Aged ; Adult ; Aged ; Cerebral Cortex/metabolism ; Cerebral Cortex/diagnostic imaging ; Cerebral Cortex/pathology ; Multiple Sclerosis, Relapsing-Remitting/metabolism ; Multiple Sclerosis, Relapsing-Remitting/diagnostic imaging ; Multiple Sclerosis, Relapsing-Remitting/pathology ; Magnetic Resonance Imaging ; Multiple Sclerosis, Chronic Progressive/metabolism ; Multiple Sclerosis, Chronic Progressive/diagnostic imaging ; Multiple Sclerosis, Chronic Progressive/pathology ; Acetamides ; Pyridines

المؤلفون: D'Ambrosio A; Department of Neuroscience, Istituto Superiore di Sanità, Vle Regina Elena 299, 00161, Rome, Italy., Zamboni S; Department of Neuroscience, Istituto Superiore di Sanità, Vle Regina Elena 299, 00161, Rome, Italy., Camerini S; Core Facilities, Istituto Superiore di Sanità, 00161, Rome, Italy., Casella M; Core Facilities, Istituto Superiore di Sanità, 00161, Rome, Italy., Sanchez M; Core Facilities, Istituto Superiore di Sanità, 00161, Rome, Italy., Pietraforte D; Core Facilities, Istituto Superiore di Sanità, 00161, Rome, Italy., Vanacore N; Center of Disease Prevention and Health Promotion, Istituto Superiore di Sanità, 00161, Rome, Italy., Diociauti M; Center of Disease Prevention and Health Promotion, Istituto Superiore di Sanità, 00161, Rome, Italy., Altieri M; Department of Human Neurosciences, University 'La Sapienza', 00185, Rome, Italy., Di Piero V; Department of Human Neurosciences, University 'La Sapienza', 00185, Rome, Italy., Francia A; Department of Human Neurosciences, University 'La Sapienza', 00185, Rome, Italy., Pontecorvo S; Department of Human Neurosciences, University 'La Sapienza', 00185, Rome, Italy., Puthenparampil M; Department of Neurosciences, University of Padua, 35128, Padua, Italy., Gallo P; Department of Neurosciences, University of Padua, 35128, Padua, Italy., Margutti P; Department of Neuroscience, Istituto Superiore di Sanità, Vle Regina Elena 299, 00161, Rome, Italy. paola.margutti@iss.it.

المصدر: Journal of neuroinflammation [J Neuroinflammation] 2024 Sep 02; Vol. 21 (1), pp. 217. Date of Electronic Publication: 2024 Sep 02.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101222974 Publication Model: Electronic Cited Medium: Internet ISSN: 1742-2094 (Electronic) Linking ISSN: 17422094 NLM ISO Abbreviation: J Neuroinflammation Subsets: MEDLINE

مواضيع طبية MeSH: Extracellular Vesicles*/metabolism , Proteomics*/methods , Excitatory Amino Acid Transporter 2* , Multiple Sclerosis*/cerebrospinal fluid , Multiple Sclerosis*/blood, Humans ; Male ; Female ; Adult ; Middle Aged ; Biomarkers/blood ; Biomarkers/cerebrospinal fluid ; Multiple Sclerosis, Relapsing-Remitting/cerebrospinal fluid ; Multiple Sclerosis, Relapsing-Remitting/blood ; Cohort Studies

المؤلفون: Ayrignac X; University of Montpellier, INM, INSERM, MS referral center & reference center for adult-onset leukodystrophies, CHU Montpellier, Montpellier, France. Electronic address: x-ayrignac@chu-montpellier.fr., Aouinti S; Clinical Research and Epidemiology Unit, CHU Montpellier, Univ Montpellier, Montpellier, France., Vincent T; University of Montpellier, INM, INSERM, CHU Montpellier, Department of Immunology, CHU Montpellier, Montpellier, France., Carra-Dallière C; University of Montpellier, INM, INSERM, MS referral center & reference center for adult-onset leukodystrophies, CHU Montpellier, Montpellier, France., Charif M; University of Montpellier, INM, INSERM, MS referral center & reference center for adult-onset leukodystrophies, CHU Montpellier, Montpellier, France., Duflos C; Clinical Research and Epidemiology Unit, CHU Montpellier, Univ Montpellier, Montpellier, France., Hirtz C; University of Montpellier, IRMB CHU de Montpellier, INM INSERM, Montpellier, France., Dos Santos A; Department of Neurology, CHU de Poitiers, Poitiers, France., Menjot de Champfleur N; University of Montpellier, INSERM, CHU Montpellier, CNRS, Department of Neuroradiology, CHU Montpellier, Montpellier, France., Labauge P; University of Montpellier, INM, INSERM, MS referral center & reference center for adult-onset leukodystrophies, CHU Montpellier, Montpellier, France., Lehmann S; University of Montpellier, IRMB CHU de Montpellier, INM INSERM, Montpellier, France.

المصدر: Multiple sclerosis and related disorders [Mult Scler Relat Disord] 2024 Sep; Vol. 89, pp. 105747. Date of Electronic Publication: 2024 Jun 24.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier B. V Country of Publication: Netherlands NLM ID: 101580247 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2211-0356 (Electronic) Linking ISSN: 22110348 NLM ISO Abbreviation: Mult Scler Relat Disord Subsets: MEDLINE

مواضيع طبية MeSH: Glial Fibrillary Acidic Protein*/blood , Neurofilament Proteins*/blood , Disease Progression* , Biomarkers*/blood , Multiple Sclerosis, Relapsing-Remitting*/blood , Multiple Sclerosis, Relapsing-Remitting*/diagnostic imaging , Multiple Sclerosis, Relapsing-Remitting*/diagnosis, Humans ; Male ; Female ; Adult ; Prognosis ; Follow-Up Studies ; Middle Aged ; Multiple Sclerosis, Chronic Progressive/blood ; Multiple Sclerosis, Chronic Progressive/diagnostic imaging ; Multiple Sclerosis, Chronic Progressive/diagnosis

المؤلفون: Sainz-Amo R; Neurology Department, Hospital Universitario Ramón y Cajal, La Red Española de Esclerosis Multiple, Red de Enfermedades Inflamatorias, Instituto de Salud Carlos III (ISCIII), Instituto Ramón y Cajal de Investigación Sanitaria, Madrid, Spain.; Immunology Department, Hospital Universitario Ramón y Cajal, La Red Española de Esclerosis Multiple, Red de Enfermedades Inflamatorias, Instituto de Salud Carlos III, Instituto Ramón y Cajal de Investigación Sanitaria, Madrid, Spain., Rodero Romero A; Immunology Department, Hospital Universitario Ramón y Cajal, La Red Española de Esclerosis Multiple, Red de Enfermedades Inflamatorias, Instituto de Salud Carlos III, Instituto Ramón y Cajal de Investigación Sanitaria, Madrid, Spain., Monreal E; Neurology Department, Hospital Universitario Ramón y Cajal, La Red Española de Esclerosis Multiple, Red de Enfermedades Inflamatorias, Instituto de Salud Carlos III (ISCIII), Instituto Ramón y Cajal de Investigación Sanitaria, Madrid, Spain., Chico García JL; Neurology Department, Hospital Universitario Ramón y Cajal, La Red Española de Esclerosis Multiple, Red de Enfermedades Inflamatorias, Instituto de Salud Carlos III (ISCIII), Instituto Ramón y Cajal de Investigación Sanitaria, Madrid, Spain., Fernández Velasco JI; Immunology Department, Hospital Universitario Ramón y Cajal, La Red Española de Esclerosis Multiple, Red de Enfermedades Inflamatorias, Instituto de Salud Carlos III, Instituto Ramón y Cajal de Investigación Sanitaria, Madrid, Spain., Villarrubia N; Immunology Department, Hospital Universitario Ramón y Cajal, La Red Española de Esclerosis Multiple, Red de Enfermedades Inflamatorias, Instituto de Salud Carlos III, Instituto Ramón y Cajal de Investigación Sanitaria, Madrid, Spain., Veiga González JL; Immunology Department, Hospital Universitario Ramón y Cajal, La Red Española de Esclerosis Multiple, Red de Enfermedades Inflamatorias, Instituto de Salud Carlos III, Instituto Ramón y Cajal de Investigación Sanitaria, Madrid, Spain., Sainz de la Maza S; Neurology Department, Hospital Universitario Ramón y Cajal, La Red Española de Esclerosis Multiple, Red de Enfermedades Inflamatorias, Instituto de Salud Carlos III (ISCIII), Instituto Ramón y Cajal de Investigación Sanitaria, Madrid, Spain., Rodríguez Jorge F; Neurology Department, Hospital Universitario Ramón y Cajal, La Red Española de Esclerosis Multiple, Red de Enfermedades Inflamatorias, Instituto de Salud Carlos III (ISCIII), Instituto Ramón y Cajal de Investigación Sanitaria, Madrid, Spain., Masjuan J; Neurology Department, Hospital Universitario Ramón y Cajal, La Red Española de Esclerosis Multiple, Red de Enfermedades Inflamatorias, Instituto de Salud Carlos III (ISCIII), Instituto Ramón y Cajal de Investigación Sanitaria, Madrid, Spain., Costa-Frossard L; Neurology Department, Hospital Universitario Ramón y Cajal, La Red Española de Esclerosis Multiple, Red de Enfermedades Inflamatorias, Instituto de Salud Carlos III (ISCIII), Instituto Ramón y Cajal de Investigación Sanitaria, Madrid, Spain., Villar LM; Immunology Department, Hospital Universitario Ramón y Cajal, La Red Española de Esclerosis Multiple, Red de Enfermedades Inflamatorias, Instituto de Salud Carlos III, Instituto Ramón y Cajal de Investigación Sanitaria, Madrid, Spain.

المصدر: Frontiers in immunology [Front Immunol] 2024 Aug 19; Vol. 15, pp. 1454474. Date of Electronic Publication: 2024 Aug 19 (Print Publication: 2024).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

مواضيع طبية MeSH: Alemtuzumab*/therapeutic use , Neurofilament Proteins*/blood , Multiple Sclerosis, Relapsing-Remitting*/drug therapy , Multiple Sclerosis, Relapsing-Remitting*/blood , Multiple Sclerosis, Relapsing-Remitting*/immunology , Glial Fibrillary Acidic Protein*/blood, Humans ; Female ; Male ; Adult ; Prospective Studies ; Biomarkers/blood ; Treatment Outcome ; Immunologic Factors/therapeutic use ; Multiple Sclerosis/drug therapy ; Multiple Sclerosis/blood

المؤلفون: Jansen MI; Laboratory of Cellular & Molecular Neuroscience (LCMN), School of Life Sciences, Faculty of Science, University of Technology Sydney, P.O. Box 123, Sydney, NSW 2007, Australia., Musumeci G; Department of Biomedical and Biotechnological Sciences, Human Anatomy and Histology Section, School of Medicine, University of Catania, 95123 Catania, Italy., Castorina A; Laboratory of Cellular & Molecular Neuroscience (LCMN), School of Life Sciences, Faculty of Science, University of Technology Sydney, P.O. Box 123, Sydney, NSW 2007, Australia.

المصدر: International journal of molecular sciences [Int J Mol Sci] 2024 Aug 14; Vol. 25 (16). Date of Electronic Publication: 2024 Aug 14.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE

مواضيع طبية MeSH: White Matter*/metabolism , White Matter*/pathology , Multiple Sclerosis*/metabolism , Multiple Sclerosis*/pathology , Pituitary Adenylate Cyclase-Activating Polypeptide*/metabolism , Vasoactive Intestinal Peptide*/metabolism, Humans ; Male ; Middle Aged ; Female ; Adult ; Receptors, Vasoactive Intestinal Peptide, Type II/metabolism ; Receptors, Vasoactive Intestinal Peptide, Type II/genetics ; Aged ; Receptors, Vasoactive Intestinal Polypeptide, Type I/metabolism ; Receptors, Vasoactive Intestinal Polypeptide, Type I/genetics ; Autopsy ; Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I/metabolism ; Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I/genetics ; Central Nervous System/metabolism ; Central Nervous System/pathology ; Multiple Sclerosis, Relapsing-Remitting/metabolism ; Multiple Sclerosis, Relapsing-Remitting/pathology

المؤلفون: Mariottini A; Department of Neurofarba, University of Florence, Florence, Italy; Department of Neurology 2 and Tuscan Region Multiple Sclerosis Referral Centre, Careggi University Hospital, Florence, Italy., Stack EH; National Institute of Neurological Disorders and Stroke, NIH, Bethesda, MD, 20892 USA., Nair G; National Institute of Neurological Disorders and Stroke, NIH, Bethesda, MD, 20892 USA., Nozzoli C; Cell Therapy and Transfusion Medicine Unit, Careggi University Hospital, Florence, Italy., Wu T; National Institute of Neurological Disorders and Stroke, NIH, Bethesda, MD, 20892 USA., Marchi L; Department of Neurofarba, University of Florence, Florence, Italy., Boncompagni R; Cell Therapy and Transfusion Medicine Unit, Careggi University Hospital, Florence, Italy., Repice AM; Department of Neurology 2 and Tuscan Region Multiple Sclerosis Referral Centre, Careggi University Hospital, Florence, Italy., Fainardi E; Neuroradiology Unit, Department of Experimental and Clinical Biomedical Sciences 'Mario Serio', University of Florence, Florence, Italy; Neuroradiology Unit, Department of Radiology, Careggi University Hospital, Florence, Italy., Pasquale FD; Diagnostic Imaging Unit, Department of Experimental and Clinical Biomedical Sciences, University of Florence, Florence, Italy., Carlesi E; Neuroradiology Unit, Department of Radiology, Careggi University Hospital, Florence, Italy., Saccardi R; Cell Therapy and Transfusion Medicine Unit, Careggi University Hospital, Florence, Italy., Jacobson S; National Institute of Neurological Disorders and Stroke, NIH, Bethesda, MD, 20892 USA., Massacesi L; Department of Neurofarba, University of Florence, Florence, Italy; Department of Neurology 2 and Tuscan Region Multiple Sclerosis Referral Centre, Careggi University Hospital, Florence, Italy. Electronic address: massacesi@unifi.it.

المصدر: Multiple sclerosis and related disorders [Mult Scler Relat Disord] 2024 Aug; Vol. 88, pp. 105745. Date of Electronic Publication: 2024 Jun 26.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier B. V Country of Publication: Netherlands NLM ID: 101580247 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2211-0356 (Electronic) Linking ISSN: 22110348 NLM ISO Abbreviation: Mult Scler Relat Disord Subsets: MEDLINE

مواضيع طبية MeSH: Hematopoietic Stem Cell Transplantation* , Magnetic Resonance Imaging* , Multiple Sclerosis, Relapsing-Remitting*/diagnostic imaging , Multiple Sclerosis, Relapsing-Remitting*/therapy , Multiple Sclerosis, Relapsing-Remitting*/pathology , Multiple Sclerosis, Relapsing-Remitting*/physiopathology , Spinal Cord*/diagnostic imaging , Spinal Cord*/pathology, Humans ; Female ; Male ; Adult ; Middle Aged ; Multiple Sclerosis, Chronic Progressive/diagnostic imaging ; Multiple Sclerosis, Chronic Progressive/therapy ; Disease Progression ; Atrophy ; Follow-Up Studies ; Brain/diagnostic imaging ; Brain/pathology ; Biomarkers

المؤلفون: Lorefice L; Multiple Sclerosis Center, Department of Medical Sciences and Public Health, University of Cagliari, via Is Guadazzonis 2, 09126, Cagliari, Italy. lorena.lorefice@hotmail.it., Mellino P; Multiple Sclerosis Center, Department of Medical Sciences and Public Health, University of Cagliari, via Is Guadazzonis 2, 09126, Cagliari, Italy., Frau J; Multiple Sclerosis Center, Department of Medical Sciences and Public Health, University of Cagliari, via Is Guadazzonis 2, 09126, Cagliari, Italy., Coghe G; Multiple Sclerosis Center, Department of Medical Sciences and Public Health, University of Cagliari, via Is Guadazzonis 2, 09126, Cagliari, Italy., Fenu G; Department of Neurosciences, ARNAS Brotzu, Cagliari, Italy., Cocco E; Multiple Sclerosis Center, Department of Medical Sciences and Public Health, University of Cagliari, via Is Guadazzonis 2, 09126, Cagliari, Italy.

المصدر: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology [Neurol Sci] 2024 Aug; Vol. 45 (8), pp. 3951-3959. Date of Electronic Publication: 2024 Mar 12.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer-Verlag Italia Country of Publication: Italy NLM ID: 100959175 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1590-3478 (Electronic) Linking ISSN: 15901874 NLM ISO Abbreviation: Neurol Sci Subsets: MEDLINE

مواضيع طبية MeSH: Antibodies, Monoclonal, Humanized*/therapeutic use , Immunologic Factors*/therapeutic use , Multiple Sclerosis, Relapsing-Remitting*/drug therapy, Humans ; Female ; Male ; Adult ; Middle Aged ; Multiple Sclerosis, Chronic Progressive/drug therapy ; Retrospective Studies ; Treatment Outcome ; Multiple Sclerosis/drug therapy

المؤلفون: Mavandadi S; BouAliSina Hospital, Qazvin University of Medical Sciences, Qazvin, Iran., Paybast S; Department of Neurology, Imam Hossein Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran., Mirzadeh M; Metabolic Diseases Research Center, Research Institute for Non-Communicable Diseases, Qazvin University of Medical Sciences, Qazvin, Iran., Mozhdehipanah H; Department of Neurology, BouAliSina Hospital, Qazvin University of Medical Sciences, Qazvin, Iran. hmozhdehip@yahoo.com.

المصدر: Acta neurologica Belgica [Acta Neurol Belg] 2024 Aug; Vol. 124 (4), pp. 1289-1294. Date of Electronic Publication: 2024 Apr 06.

نوع المنشور: Journal Article; Randomized Controlled Trial

بيانات الدورية: Publisher: Springer Country of Publication: Italy NLM ID: 0247035 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2240-2993 (Electronic) Linking ISSN: 03009009 NLM ISO Abbreviation: Acta Neurol Belg Subsets: MEDLINE

مواضيع طبية MeSH: 4-Aminopyridine*/therapeutic use , 4-Aminopyridine*/administration & dosage , Fatigue*/drug therapy , Fatigue*/etiology , Multiple Sclerosis*/complications , Multiple Sclerosis*/drug therapy, Humans ; Female ; Male ; Adult ; Double-Blind Method ; Middle Aged ; Potassium Channel Blockers/therapeutic use ; Potassium Channel Blockers/administration & dosage ; Treatment Outcome ; Multiple Sclerosis, Relapsing-Remitting/drug therapy ; Multiple Sclerosis, Relapsing-Remitting/complications